Skip to content
Search

Latest Stories

NI community pharmacy gets additional £8m investment

The Northern Ireland government has announced an additional investment of £8m into community pharmacy to support the phased introduction of a new medicines adherence service in the country.

The service will help to ensure that people at high risk of harm from poor adherence to their medication will receive tailored support to assist them to take their medicines on time and as prescribed. It will be introduced in phases over the coming months to allow a standard approach for new patients who need access to additional support. Phase one will involve patients being discharged from hospital with complex needs relating to their medication


Health Minister Robin Swann said: “I am delighted to be able to announce this further additional investment of £8m into community pharmacy. This funding will immediately benefit those patients being discharged from hospital with complex medication needs.”

He continued: “I am very pleased to also give my support to an agreed three year community pharmacy commissioning plan for 2022-25 which, subject to funding being in place, will provide a coherent structure for the provision of community pharmacy services over the next 36 months. The 2022-25 commissioning plan continues to build on the successful commissioning agreements that have been in place over the last two years and ensures that community pharmacies will continue to provide a number of additional services to meet the needs of patients.”

Cathy Harrison, Chief Pharmaceutical Officer at the Department of Health said: “Community pharmacies provide highly trusted and accessible services involving the safe supply of medicines, vaccines and pharmaceutical advice. Today’s announcement will help ensure that services can be developed to provide tailored support to people who need help to take their medicines safely, on time and as prescribed.”

Joe Brogan, Head of Pharmacy and Medicines Management at the Health and Social Care Board said: “Community pharmacies have provided much needed additional services during the response to COVID-19. We very much value how pharmacy staff responded to the needs of our communities and recognise the challenges that were faced. Learning from this, we have jointly developed a 3-year commissioning plan which prioritises and seeks to extend clinical services from community pharmacies.”

Gerard Greene, Chief Executive of Community Pharmacy Northern Ireland said: “This is a welcome and much needed investment in community pharmacy. It comes after two years of a pandemic, where we have clearly seen how important community pharmacy is in supporting patients and enabling them to access a vital health service. The Minister’s commitment to a new three year commissioning plan gives us more certainty and will mean we can now develop and plan new services.

“In addition, the investment in the medicines adherence service will allow community pharmacists to work directly with hospitals to ensure that patients who are being discharged and in need of specialised medicine support, can now receive that from their local pharmacy. This will have a positive impact in getting patients out of hospital more quickly and will mean they can be cared for at home.”

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less